Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3979895

Cc1ccccc1-c1cccc(C(N)=O)c1OCCN.O=C(O)C(F)(F)F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MYC P01106 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.36
PDK2 Q15119 1/20 0.36
TACR1 P25103 1/20 0.35
BCAT2 O15382 1/20 0.35
SIRT2 Q8IXJ6 1/20 0.35
SYK P43405 1/20 0.35
AURKB Q96GD4 1/20 0.35
HTT P42858 1/20 0.34
MEN1 O00255 1/20 0.34
NR1I2 O75469 1/20 0.34
LMNA P02545 1/20 0.34
CHRM2 P08172 1/20 0.34
CYP3A4 P08684 1/20 0.34
ADRA2A P08913 1/20 0.34
MAPT P10636 1/20 0.34
OPRK1 P41145 1/20 0.34
HTR2B P41595 1/20 0.34
SLC6A3 Q01959 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5067779 0.79 MYC (0.47) MYCL3MBTL1PDK2TACR1BCAT2
Trifluoroacetic Acid SCHEMBL1786800 0.73 NPC1 (0.45) MYCL3MBTL1BCAT2HTTLMNA
Trifluoroacetic Acid SCHEMBL5072107 0.73 NPC1 (0.45) MYCL3MBTL1BCAT2HTTLMNA
SCHEMBL26919137 0.73 IRAK4 (0.41) MYCL3MBTL1PDK2TACR1BCAT2
SCHEMBL29057024 0.71 ALDH1A1 (0.57) MYCL3MBTL1MEN1CYP3A4KMT2A
Trifluoroacetic Acid SCHEMBL27999207 0.71 L3MBTL1 (0.44) MYCL3MBTL1PDK2BCAT2HTT
Trifluoroacetic Acid SCHEMBL4629336 0.70 FFAR1 (0.45) MYCPDK2TACR1FFAR1FFAR4
Trifluoroacetic Acid SCHEMBL6382776 0.69 TAAR1 (0.68) HDAC6
SCHEMBL3701689 0.69 MYC (0.51) MYCL3MBTL1BCAT2HTTLMNA
Trifluoroacetic Acid SCHEMBL5615001 0.69 CHIT1 (0.42) MYCL3MBTL1HTTLMNACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054383-A2 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS SmithKline Beecham Corporation (US) 2009-05-06 EP disclosed
WO-2008021849-A2 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS SMITHKLINE BEECHAM CORPORATION (US) 2008-02-21 WO disclosed